Radiofrequency and pelvic floor exercises for pelvic floor problems after breast cancer
Official title: Effectiveness of Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunction in Breast Cancer Patients.
Run by Cardenal Herrera University · NCT06694519 · Data updated 2026-11-12
This project will test whether radiofrequency, pelvic floor muscle exercises, or both can reduce pelvic floor and genitourinary symptoms in women who had breast cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 117 (estimated) |
| Sponsor | Cardenal Herrera University Academic / other |
| Locations | 1 site (Elche, Spain / Valencia) |
| Status | Recruiting |
| Started | January 30, 2025 |
| Main results expected | December 30, 2025 |
| Study ends | January 30, 2027 |
| Registry record updated | January 21, 2026 |
| Trial ID | NCT06694519 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult women with a history of stage 1–2 breast cancer (medical discharge >1 year), a high pelvic floor symptom score (PFDI-20 ≥ 100), and no recent PFMT, RF, laser, or hormonal treatments and no contraindications to therapy.
✕Probably not a fit
Patients who cannot contract their pelvic floor, who have recent use of vaginal estrogens or systemic hormones, pacemakers, active pelvic infections, recent pelvic surgery, or significant neurological or cardiac disease are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
A randomized, double-blind trial at Cardenal Herrera University in Elche, Spain will enroll women with stage 1–2 breast cancer who have pelvic floor dysfunction. Participants will be randomly assigned to pelvic floor muscle training (PFMT), radiofrequency (RF) therapy, or combined PFMT+RF, with treatments delivered onsite. Outcomes include pelvic floor manometry (PHENIX LIBERTY), validated questionnaires (PFIQ-20, ICIQ-SF), Sandvik test, and the vaginal health index to measure symptom and functional change. Key exclusions include recent pelvic therapies or hormones, inability to contract the pelvic floor, pacemakers, active pelvic infections, and major neurological or cardiac conditions.
Why it matters
Potential benefit: If successful, these treatments could reduce urinary and vaginal symptoms and improve quality of life for breast cancer survivors who often cannot use local estrogen.
How similar studies have gone: Pelvic floor muscle training has strong evidence for treating incontinence, while vaginal radiofrequency is a newer approach with some promising but limited high-quality evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * women of legal age with a clinical history of breast cancer, who agree to participate in the study and who present pelvic dysfunction assessed by the Pelvic Floor Distress Inventory (PFDI20) ≥ 100 * women survivors of stage 1 and 2 breast cancer * A medical discharge was granted more than one year ago * A diagnosis of another type of cancer has not been made. Exclusion Criteria: * Having performed PMFT or received RF in the last 12 months * Use of vaginal oestrogens in the last 6 months * Systemic hormone therapy in the last 6 months * Laser therapy in the last 6 months * Absence of pelvic floor contraction according to the Modified Oxford Scale * Use of pacemaker * Use of heart pacemaker, decompensated heart or metabolic diseases, cognitive deficits, peripheral or central neurological disorders, previous surgeries in the pelvic region, skin pathologies or wounds in the treatment area or presence of an active urinary tract and/or vaginal infection.
Where it's running
-
Cardenal Herrera - Ceu
Elche, Spain / Valencia, Spain Recruiting
Study contacts
- Principal investigator: ANA LOZANO, MsC — Cardenal Herrera - Ceu; Ceu Universities
- Study coordinator: SERGIO MONTERO-NAVARRO, PhD
- Email: sergio.montero@uchceu.es
- Phone: +34 965426486
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
Nurse-led programs mixing exercise and psychology to help people with chronic kidney disease
This study tests whether a nurse-led program that combines physical exercise and psychosocial support can improve outcomes for adults with chronic renal failure on dialysis or in hospital.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.